Table 1 Characteristics (mean (standard deviation) or percentage) of the GOLDN Study sample
| Â | Participants with adiponectin measured at baseline (n = 1121) | Participants with adiponectin measured at both baseline and post-fenofibrate trial (n = 859) |
|---|---|---|
Age (years) | 48.2 (16.3) | 48.3 (15.9) |
BMI (kg/m2)†| 28.3 (5.6) | 28.5 (5.5) |
Baseline plasma adiponectin (μg/ml)* | 7.4 (4.8 – 10.5) | 7.2 (4.7 – 10.2) |
Post-trial plasma adiponectin (μg/ml)* | -- | 7.0 (4.5 – 9.9) |
Male (%) | 48.1 | 49.6 |
Center (%) | Â | Â |
   Minnesota | 51.3 | 49.9 |
   Utah | 48.7 | 51.1 |